Cimzia Európai Unió - magyar - EMA (European Medicines Agency)

cimzia

ucb pharma sa - a certolizumab pegol - crohn-betegség - immunszuppresszánsok - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. vártak a cimzia-tól monoterápiaként intolerancia esetén, metotrexát, vagy ha a folyamatos metotrexát-kezelés nem megfelelő. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.